XLIFE SCIENCES AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34 CHF | -2.58% |
|
-5.56% | -31.86% |
| 04-23 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
| 02-29 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 218M | - | - | - | - | - | |
| 56.61B | - | |||||
| 39.62B | ||||||
| 39.25B | ||||||
| 28.28B | ||||||
| 26.44B |
- Stock Market
- Equities
- XLS Stock
- Charts Xlife Sciences AG
- Sector Chart
